The Effect of Systemic Treatment on Different Anatomical Regions in Pediatric Patients with Atopic Dermatitis: Real-World Data from PEDISTAD

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY(2023)

引用 0|浏览6
暂无评分
摘要
Background: In phase-3 clinical trials, dupilumab significantly improved disease severity in patients with moderate-to-severe atopic dermatitis (AD). Systemic drugs are used in children with AD, however, their real-world impact across anatomical regions is unknown.
更多
查看译文
关键词
atopic dermatitis,pediatric patients,systemic treatment,real-world
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要